Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-12-29 Purchase | 2022-01-03 7:57 pm | BridgeBio Pharma Inc. | BBIO | Lo Andrew Director | 7,500 | $13.18 | $98,850 | 253,682 (Indirect Direct) | View |
| 2019-06-17 Purchase | 2019-06-19 6:20 pm | Urovant Sciences Ltd. | UROV | Lo Andrew 10% Owner | 18,204 | $8.3158 | $151,381 | 22,860,013 (Indirect) | View |
| 2019-06-12 Purchase | 2019-06-14 6:30 pm | Urovant Sciences Ltd. | UROV | Lo Andrew 10% Owner | 22,011 | $8.0551 | $177,301 | 22,841,809 (Indirect) | View |
| 2019-06-07 Purchase | 2019-06-11 6:05 pm | Urovant Sciences Ltd. | UROV | Lo Andrew 10% Owner | 21,338 | $8.3067 | $177,247 | 22,819,798 (Indirect) | View |
| 2019-06-04 Purchase | 2019-06-06 6:08 pm | Urovant Sciences Ltd. | UROV | Lo Andrew 10% Owner | 21,122 | $7.8567 | $165,950 | 22,798,460 (Indirect) | View |
| 2019-06-04 Purchase | 2019-06-06 6:07 pm | Myovant Sciences Ltd. | MYOV | Lo Andrew 10% Owner | 2,424,242 | $8.25 | $19,999,997 | 40,765,599 (Indirect) | View |
| 2019-05-30 Purchase | 2019-06-03 6:13 pm | Urovant Sciences Ltd. | UROV | Lo Andrew 10% Owner | 17,746 | $7.8297 | $138,946 | 22,777,338 (Indirect) | View |
| 2019-05-24 Purchase | 2019-05-29 6:12 pm | Urovant Sciences Ltd. | UROV | Lo Andrew 10% Owner | 14,485 | $7.6259 | $110,461 | 22,759,592 (Indirect) | View |
| 2019-05-21 Purchase | 2019-05-23 6:21 pm | Urovant Sciences Ltd. | UROV | Lo Andrew 10% Owner | 19,830 | $8.2158 | $162,918 | 22,745,107 (Indirect) | View |
| 2019-05-16 Purchase | 2019-05-20 6:46 pm | Urovant Sciences Ltd. | UROV | Lo Andrew 10% Owner | 21,608 | $7.5381 | $162,884 | 22,725,277 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-06-21 Option Award | 2023-06-23 4:21 pm | N/A 2033-06-21 | BridgeBio Pharma Inc. | BBIO | Lo Andrew Director | 51,501 | $0 | 51,501 (Direct) | View |
| 2022-12-01 Option Award | 2022-12-05 12:34 pm | 2024-06-15 2032-12-01 | AbCellera Biologics Inc. | ABCL | Lo Andrew Director | 47,231 | $0 | 138,556 (Direct) | View |
| 2022-09-15 Option Award | 2022-09-19 9:53 pm | N/A 2032-09-14 | Roivant Sciences Ltd. | ROIV | Lo Andrew Director | 123,992 | $0 | 123,992 (Direct) | View |
| 2022-06-22 Option Award | 2022-06-24 4:31 pm | N/A 2032-06-22 | BridgeBio Pharma Inc. | BBIO | Lo Andrew Director | 104,921 | $0 | 104,921 (Direct) | View |
| 2021-12-03 Option Award(A) | 2021-12-10 2:36 pm | N/A 2031-12-03 | AbCellera Biologics Inc. | ABCL | Lo Andrew Director | 91,325 | $0 | 91,325 (Direct) | View |
Ownership | 2021-10-01 5:39 pm | N/A 2026-10-19 | Roivant Sciences Ltd. | ROIV | Lo Andrew Director | 0 | $0 | 690,583 (Direct) | View |
| 2021-06-17 Option Award | 2021-06-22 7:38 pm | N/A 2031-06-16 | BridgeBio Pharma Inc. | BBIO | Lo Andrew Director | 38,895 | $0 | 38,895 (Direct) | View |
| 2020-06-23 Option Award | 2020-06-25 4:38 pm | N/A 2030-06-22 | BridgeBio Pharma Inc. | BBIO | Lo Andrew Director | 101,223 | $0 | 101,223 (Direct) | View |
Ownership | 2020-06-25 4:35 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | Lo Andrew Director | 0 | $0 | 246,182 (Direct) | View |